FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2054727157> ?p ?o ?g. }

• W2054727157 endingPage "S18" @default.
• W2054727157 startingPage "S3" @default.
• W2054727157 abstract "In postmenopausal women, the use of aromatase inhibitors increases bone turnover and induces bone loss at sites rich in trabecular bone at an average rate of 1–3% per year leading to an increase in fracture incidence compared to that seen during tamoxifen use. The bone loss is much more marked in young women with treatment-induced ovarian suppression followed by aromatase inhibitor therapy (average 7–8% per annum). Pre-treatment with tamoxifen for 2–5 years may reduce the clinical significance of the adverse bone effects associated with aromatase inhibitors, particularly if this leads to a shortening in the duration of exposure to an aromatase inhibitor. However, skeletal status should still be assessed at the commencement of aromatase inhibitor therapy. The rate of bone loss in women who experience a premature menopause before the age of 45 or are receiving ovarian suppression therapy is accelerated by the concomitant use of aromatase inhibitors. These patients are considered to be at high risk of clinically important bone loss and should have a baseline dual energy X-ray absorptiometry (DXA) assessment of bone mineral density (BMD). Randomised clinical trials in postmenopausal women indicate that bisphosphonates prevent the bone loss and accelerated bone turnover associated with aromatase inhibitor therapy and are a promising strategy for the prevention and treatment of osteoporosis in this setting. Treatment initiation recommendations are based on a combination of risk factors for osteoporotic fracture and BMD levels. Bisphosphonates, along with a healthy lifestyle and adequate intake of calcium and vitamin D are the treatments of choice to prevent bone loss. Due to the rate of bone loss associated with breast cancer treatments, and uncertainties about the interaction between aromatase inhibitor use and BMD for fracture risk, the threshold for intervention has been set at a higher level than that generally recommended for postmenopausal osteoporosis. Management recommendations have been summarised in two algorithms, one for women experiencing a premature menopause and the other for postmenopausal women requiring adjuvant aromatase inhibitor therapy." @default.
• W2054727157 created "2016-06-24" @default.
• W2054727157 creator A5006031151 @default.
• W2054727157 creator A5007727706 @default.
• W2054727157 creator A5016379322 @default.
• W2054727157 creator A5020868945 @default.
• W2054727157 creator A5037004738 @default.
• W2054727157 creator A5051980635 @default.
• W2054727157 creator A5058219705 @default.
• W2054727157 creator A5064307236 @default.
• W2054727157 creator A5078650311 @default.
• W2054727157 date "2008-01-01" @default.
• W2054727157 modified "2023-10-17" @default.
• W2054727157 title "Guidance for the management of breast cancer treatment-induced bone loss: A consensus position statement from a UK Expert Group" @default.
• W2054727157 cites W1529243395 @default.
• W2054727157 cites W1531964529 @default.
• W2054727157 cites W1761951195 @default.
• W2054727157 cites W1800396987 @default.
• W2054727157 cites W1936024593 @default.
• W2054727157 cites W1961026612 @default.
• W2054727157 cites W1972546618 @default.
• W2054727157 cites W1976231681 @default.
• W2054727157 cites W1976680910 @default.
• W2054727157 cites W1977365834 @default.
• W2054727157 cites W1981476886 @default.
• W2054727157 cites W1985650168 @default.
• W2054727157 cites W1990173735 @default.
• W2054727157 cites W2000519574 @default.
• W2054727157 cites W2004236425 @default.
• W2054727157 cites W2014926793 @default.
• W2054727157 cites W2018994395 @default.
• W2054727157 cites W2022743602 @default.
• W2054727157 cites W2031777038 @default.
• W2054727157 cites W2031856151 @default.
• W2054727157 cites W2031984617 @default.
• W2054727157 cites W2033401946 @default.
• W2054727157 cites W2040156285 @default.
• W2054727157 cites W2040223224 @default.
• W2054727157 cites W2042683095 @default.
• W2054727157 cites W2045222050 @default.
• W2054727157 cites W2047135480 @default.
• W2054727157 cites W2047486987 @default.
• W2054727157 cites W2049810240 @default.
• W2054727157 cites W2053194047 @default.
• W2054727157 cites W2065380630 @default.
• W2054727157 cites W2066812220 @default.
• W2054727157 cites W2074089512 @default.
• W2054727157 cites W2081333800 @default.
• W2054727157 cites W2086615312 @default.
• W2054727157 cites W2088014747 @default.
• W2054727157 cites W2094251460 @default.
• W2054727157 cites W2096446019 @default.
• W2054727157 cites W2096476501 @default.
• W2054727157 cites W2100291515 @default.
• W2054727157 cites W2101881391 @default.
• W2054727157 cites W2104599723 @default.
• W2054727157 cites W2106975935 @default.
• W2054727157 cites W2107118598 @default.
• W2054727157 cites W2107789045 @default.
• W2054727157 cites W2114358979 @default.
• W2054727157 cites W2121099142 @default.
• W2054727157 cites W2121656289 @default.
• W2054727157 cites W2122906075 @default.
• W2054727157 cites W2126930357 @default.
• W2054727157 cites W2127677509 @default.
• W2054727157 cites W2135255625 @default.
• W2054727157 cites W2137106918 @default.
• W2054727157 cites W2137411979 @default.
• W2054727157 cites W2139796029 @default.
• W2054727157 cites W2139959697 @default.
• W2054727157 cites W2143151890 @default.
• W2054727157 cites W2146194560 @default.
• W2054727157 cites W2151447010 @default.
• W2054727157 cites W2151845115 @default.
• W2054727157 cites W2153501496 @default.
• W2054727157 cites W2154614446 @default.
• W2054727157 cites W2158666395 @default.
• W2054727157 cites W2159858973 @default.
• W2054727157 cites W2162514583 @default.
• W2054727157 cites W2167238270 @default.
• W2054727157 cites W2170750104 @default.
• W2054727157 cites W2171033448 @default.
• W2054727157 cites W2280317859 @default.
• W2054727157 cites W2285443487 @default.
• W2054727157 cites W2313507666 @default.
• W2054727157 cites W2322274315 @default.
• W2054727157 cites W2394702150 @default.
• W2054727157 doi "https://doi.org/10.1016/j.ctrv.2008.03.007" @default.
• W2054727157 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18515009" @default.
• W2054727157 hasPublicationYear "2008" @default.
• W2054727157 type Work @default.
• W2054727157 sameAs 2054727157 @default.
• W2054727157 citedByCount "207" @default.
• W2054727157 countsByYear W20547271572012 @default.
• W2054727157 countsByYear W20547271572013 @default.
• W2054727157 countsByYear W20547271572014 @default.
• W2054727157 countsByYear W20547271572015 @default.
• W2054727157 countsByYear W20547271572016 @default.

• next